Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;88:1220-1222
doi: 10.1161/hh1201.093159
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molkentin, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molkentin, J. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Apoptosis
Right arrow Cell signalling/signal transduction
Right arrow Oxidant stress
(Circulation Research. 2001;88:1220.)
© 2001 American Heart Association, Inc.


Editorial

Calcineurin, Mitochondrial Membrane Potential, and Cardiomyocyte Apoptosis

Jeffery D. Molkentin

From the Department of Pediatrics, University of Cincinnati, Children’s Hospital Medical Center, Division of Molecular Cardiovascular Biology, Cincinnati, Ohio.

Correspondence to Jeffery D. Molkentin, PhD, Children’s Hospital Medical Center, Division of Molecular Cardiovascular Biology, 3333 Burnet Ave, Cincinnati, OH 45229-3039. E-mail jeff.molkentin@chmcc.org


Key Words: apoptosis • heart • calcineurin • mitochondria • ischemia

Mitochondria comprise {approx}30% of the total intracellular volume within a mammalian cardiomyocyte.1 2 Not surprisingly, subtle alterations in mitochondrial function or membrane potential can have a dramatic influence on cardiomyocyte energy production and, ultimately, the health of an individual cell. Indeed, cellular injury or stress stimulation directly elicits alterations in mitochondrial architecture, membrane potential, and oxidative capacity, which are associated with an irreversible loss of mitochondrial matrix contents and integral membrane protein constituents such as cytochrome c oxidase.3 The release of cytochrome c and/or mitochondrial permeability transition directly mediates cellular apoptosis through calcium-sensitive proteases or through coupling proteins that coordinate the activation of caspases and DNA fragmentation enzymes.3 Given the high intracellular content of mitochondria in cardiomyocytes and the unabated requirement for high-energy phosphate carriers to maintain ionic gradients and active force generation, coordinated disturbances in mitochondrial function can dramatically affect cell survival.

Recent investigation has suggested an emerging paradigm whereby stress-responsive intracellular signaling pathways directly and indirectly influence mitochondrial membrane potential, oxidative capacity, and the coupling of apoptosis initiating factors. For example, stress-responsive signaling through the c-Jun N-terminal kinases (JNKs) has been shown to initiate apoptosis in certain cell types by directly influencing proteins within the mitochondrial membranes.4 In addition, increased expression of the mitochondrial stabilizing Bcl proteins can be transcriptionally regulated through stress-responsive signaling pathways, which subsequently antagonize mitochondrial dysfunction and cytochrome c release.5 Activation of the intracellular kinase Akt also directly antagonizes mitochondrial-directed apoptosis by phosphorylating the mitochondrial destabilizing protein Bad, reducing cytochrome c release and caspase activation.6 . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. Kato, M. Akao, M. Matsumoto-Ida, T. Makiyama, M. Iguchi, T. Takeda, S. Shimizu, and T. Kita
The targeting of cyclophilin D by RNAi as a novel cardioprotective therapy: evidence from two-photon imaging
Cardiovasc Res, July 15, 2009; 83(2): 335 - 344.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Singh, S. M. Manda, D. Sikder, M. J. Birrer, B. A. Rothermel, D. J. Garry, and P. P. A. Mammen
Calcineurin Activates Cytoglobin Transcription in Hypoxic Myocytes
J. Biol. Chem., April 17, 2009; 284(16): 10409 - 10421.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. D. Garciarena, C. I. Caldiz, E. L. Portiansky, G. E. Chiappe de Cingolani, and I. L. Ennis
Chronic NHE-1 blockade induces an antiapoptotic effect in the hypertrophied heart
J Appl Physiol, April 1, 2009; 106(4): 1325 - 1331.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Somers, P. L. Beck, J. P. Lees-Miller, D. Roach, Y. Li, J. Guo, S. Loken, S. Zhan, L. Semeniuk, and H. J. Duff
iNOS in cardiac myocytes plays a critical role in death in a murine model of hypertrophy induced by calcineurin
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1122 - H1131.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. Stupka, J. D. Schertzer, R. Bassel-Duby, E. N. Olson, and G. S. Lynch
Calcineurin-A{alpha} activation enhances the structure and function of regenerating muscles after myotoxic injury
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R686 - R694.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H.-L. Li, M.-L. Zhuo, D. Wang, A.-B. Wang, H. Cai, L.-H. Sun, Q. Yang, Y. Huang, Y.-S. Wei, P. P. Liu, et al.
Targeted Cardiac Overexpression of A20 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction
Circulation, April 10, 2007; 115(14): 1885 - 1894.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
V. Champattanachai, R. B. Marchase, and J. C. Chatham
Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C178 - C187.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Matsumoto-Ida, M. Akao, T. Takeda, M. Kato, and T. Kita
Real-Time 2-Photon Imaging of Mitochondrial Function in Perfused Rat Hearts Subjected to Ischemia/Reperfusion
Circulation, October 3, 2006; 114(14): 1497 - 1503.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Martinez-Martinez, A. Rodriguez, M. D. Lopez-Maderuelo, I. Ortega-Perez, J. Vazquez, and J. M. Redondo
Blockade of NFAT Activation by the Second Calcineurin Binding Site
J. Biol. Chem., March 10, 2006; 281(10): 6227 - 6235.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. J. Schomisch, D. G. Murdock, N. Hedayati, J. L. Carino, E. J. Lesnefsky, and B. L. Cmolik
Cardioplegia prevents ischemia-induced transcriptional alterations of cytoprotective genes in rat hearts: A DNA microarray study
J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1151 - 1151.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. R. Zocchi, P. Contini, M. Alfano, and A. Poggi
Pertussis Toxin (PTX) B Subunit and the Nontoxic PTX Mutant PT9K/129G Inhibit Tat-Induced TGF-{beta} Production by NK Cells and TGF-{beta}-Mediated NK Cell Apoptosis
J. Immunol., May 15, 2005; 174(10): 6054 - 6061.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Nathan, I. Friehs, Y.-H. Choi, D. B. Cowan, H. Cao-Danh, F. X. McGowan, and P. J. del Nido
Cyclosporin A But Not FK-506 Protects Against Dopamine-Induced Apoptosis in the Stunned Heart
Ann. Thorac. Surg., May 1, 2005; 79(5): 1620 - 1626.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. N. Eigel, H. Gursahani, and R. W. Hadley
Na+/Ca2+ exchanger plays a key role in inducing apoptosis after hypoxia in cultured guinea pig ventricular myocytes
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1466 - H1475.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Uchiyama, R. M. Engelman, N. Maulik, and D. K. Das
Role of Akt Signaling in Mitochondrial Survival Pathway Triggered by Hypoxic Preconditioning
Circulation, June 22, 2004; 109(24): 3042 - 3049.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Kawamura, K. Ono, T. Morimoto, M. Akao, E. Iwai-Kanai, H. Wada, N. Sowa, T. Kita, and K. Hasegawa
Endothelin-1-Dependent Nuclear Factor of Activated T Lymphocyte Signaling Associates With Transcriptional Coactivator p300 in the Activation of the B Cell Leukemia-2 Promoter in Cardiac Myocytes
Circ. Res., June 11, 2004; 94(11): 1492 - 1499.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. N. Weiss, P. Korge, H. M. Honda, and P. Ping
Role of the Mitochondrial Permeability Transition in Myocardial Disease
Circ. Res., August 22, 2003; 93(4): 292 - 301.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. R. Gonzalez-Juanatey, M. J. Iglesias, C. Alcaide, R. Pineiro, and F. Lago
Doxazosin Induces Apoptosis in Cardiomyocytes Cultured In Vitro by a Mechanism That Is Independent of {alpha}1-Adrenergic Blockade
Circulation, January 7, 2003; 107(1): 127 - 131.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Pang, D. L. Hunton, P. Bounelis, and R. B. Marchase
Hyperglycemia Inhibits Capacitative Calcium Entry and Hypertrophy in Neonatal Cardiomyocytes
Diabetes, December 1, 2002; 51(12): 3461 - 3467.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. J Wilkins and J. D Molkentin
Calcineurin and cardiac hypertrophy: Where have we been? Where are we going?
J. Physiol., May 15, 2002; 541(1): 1 - 8.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. F Bueno, E. van Rooij, J. D Molkentin, P. A Doevendans, and L. J De Windt
Calcineurin and hypertrophic heart disease: novel insights and remaining questions
Cardiovasc Res, March 1, 2002; 53(4): 806 - 821.
[Abstract] [Full Text] [PDF]